Cargando…

Combination Therapy of PPARγ Ligands and Inhibitors of Arachidonic Acid in Lung Cancer

Lung cancer is the leading cause of cancer death in the United States and five-year survival remains low. Numerous studies have shown that chronic inflammation may lead to progression of carcinogenesis. As a result of inflammatory stimulation, arachidonic acid (AA) metabolism produces proliferation...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tauler, Jordi, Mulshine, James L.
Formato:	Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2008
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2652614/ https://www.ncbi.nlm.nih.gov/pubmed/19277204 http://dx.doi.org/10.1155/2008/750238

Ejemplares similares

Cytokines and Growth Factors Stimulate Hyaluronan Production: Role of Hyaluronan in Epithelial to Mesenchymal-Like Transition in Non-Small Cell Lung Cancer
por: Chow, Geraldine, et al.
Publicado: (2010)

Emerging PPARγ-Independent Role of PPARγ Ligands in Lung Diseases
por: Kulkarni, Ajit A., et al.
Publicado: (2012)

Nutraceuticals as Ligands of PPARγ
por: Penumetcha, Meera, et al.
Publicado: (2012)

Clinical Use of PPARγ Ligands in Cancer
por: Hatton, Jennifer L., et al.
Publicado: (2008)

Arachidonic Acid Metabolism Controls Macrophage Alternative Activation Through Regulating Oxidative Phosphorylation in PPARγ Dependent Manner
por: Xu, Miao, et al.
Publicado: (2021)

Effects of PPARγ Ligands on Leukemia
por: Tabe, Yoko, et al.
Publicado: (2012)

Gastrointestinal Cytoprotection by PPARγ Ligands
por: Naito, Yuji, et al.
Publicado: (2010)

An alternate binding site for PPARγ ligands
por: Hughes, Travis S., et al.
Publicado: (2014)

Cell Survival Signalling through PPARδ and Arachidonic Acid Metabolites in Neuroblastoma
por: Bell, Emma, et al.
Publicado: (2013)

Synergistic Effects of PPARγ Ligands and Retinoids in Cancer Treatment
por: Shimizu, Masahito, et al.
Publicado: (2008)

The Roles of Dietary PPARγ Ligands for Metastasis in Colorectal Cancer
por: Kuniyasu, Hiroki
Publicado: (2008)

The Key to Unlocking the Chemotherapeutic Potential of PPARγ Ligands: Having the Right Combination
por: Skelhorne-Gross, Graham, et al.
Publicado: (2012)

Mechanistic elucidation guided by covalent inhibitors for the development of anti-diabetic PPARγ ligands
por: Bae, Hwan, et al.
Publicado: (2016)

Synthesis of Phthalimide Derivatives as Potential PPAR-γ Ligands
por: Eom, So Hyeon, et al.
Publicado: (2016)

PPARα/γ-Independent Effects of PPARα/γ Ligands on Cysteinyl Leukotriene Production in Mast Cells
por: Yamashita, Masamichi
Publicado: (2008)

Ligand Modulated Antagonism of PPARγ by Genomic and Non-Genomic Actions of PPARδ
por: Gustafsson, Mattias C. U., et al.
Publicado: (2009)

Obesity-linked phosphorylation of PPARγ by cdk5 is a direct target of the anti-diabetic PPARγ ligands
por: Choi, Jang Hyun, et al.
Publicado: (2010)

A Role for the PPARγ in Cancer Therapy
por: Campbell, Moray J., et al.
Publicado: (2008)

PPARα ligand, AVE8134, and cyclooxygenase inhibitor therapy synergistically suppress lung cancer growth and metastasis
por: Wu, Lujin, et al.
Publicado: (2019)

The Role of PPARγ in the Cyclooxygenase Pathway in Lung Cancer
por: Hazra, Saswati, et al.
Publicado: (2008)

Omega-3 Fatty Acids and PPARγ in Cancer
por: Edwards, Iris J., et al.
Publicado: (2008)

Proteasome inhibitors: Their effects on arachidonic acid release from cells in culture and arachidonic acid metabolism in rat liver cells
por: Levine, Lawrence
Publicado: (2004)

Tryptophan hydroxylase (TRH) loss of function mutations in Daphnia deregulated growth, energetic, serotoninergic and arachidonic acid metabolic signalling pathways
por: Campos, Bruno, et al.
Publicado: (2019)

CDDO, a PPAR-γ ligand, inhibits TPA-induced cell migration and invasion through a PPAR-γ-independent mechanism
por: Jang, Hye-Yeon, et al.
Publicado: (2022)

PPARγ and Proline Oxidase in Cancer
por: Phang, James M., et al.
Publicado: (2008)

Electrophilic PPARγ Ligands Attenuate IL-1β and Silica-Induced Inflammatory Mediator Production in Human Lung Fibroblasts via a PPARγ-Independent Mechanism
por: Hogan, Christopher M., et al.
Publicado: (2011)

Identification of PPARγ ligands with One-dimensional Drug Profile Matching
por: Kovács, Diána, et al.
Publicado: (2013)

Cooperative cobinding of synthetic and natural ligands to the nuclear receptor PPARγ
por: Shang, Jinsai, et al.
Publicado: (2018)

The Role of PPARγ Ligands in Breast Cancer: From Basic Research to Clinical Studies
por: Augimeri, Giuseppina, et al.
Publicado: (2020)

Is arachidonic acid an endoschistosomicide?
por: Hanna, Violette Said, et al.
Publicado: (2018)

PPARγ and Apoptosis in Cancer
por: Elrod, Heath A., et al.
Publicado: (2008)

Synergistic Antiproliferative Effects of Combined γ-Tocotrienol and PPARγ Antagonist Treatment Are Mediated through PPARγ-Independent Mechanisms in Breast Cancer Cells
por: Malaviya, Abhita, et al.
Publicado: (2014)

PPARγ as a Novel Therapeutic Target in Lung Cancer
por: Reddy, Aravind T., et al.
Publicado: (2016)

PPARγ sumoylation-mediated lipid accumulation in lung cancer
por: Phan, Ai N.H., et al.
Publicado: (2017)

PPARγ Inhibitors as Novel Tubulin-Targeting Agents
por: Schaefer, Katherine L.
Publicado: (2008)

PPARγ Ligands Regulate Noncontractile and Contractile Functions of Airway Smooth Muscle: Implications for Asthma Therapy
por: Donovan, Chantal, et al.
Publicado: (2012)

PPAR Ligands for Cancer Chemoprevention
por: Yasui, Yumiko, et al.
Publicado: (2008)

Do PPARγ Ligands Suppress the Growth of Cholangiocarcinoma or the Cholangiohepatitis Induced by the Tumor?
por: Suzuki, Satoru, et al.
Publicado: (2008)

PPARγ ligands inhibit catabolic and inflammatory responses in articular joint cells
por: Fahmi, H, et al.
Publicado: (2003)

PPARγ Ligand as a Promising Candidate for Colorectal Cancer Chemoprevention: A Pilot Study
por: Takahashi, Hirokazu, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_sal5s1tk590e77qd094gtnstko